These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28185161)

  • 21. The adaptive immune system in atopic dermatitis and implications on therapy.
    Roesner LM; Werfel T; Heratizadeh A
    Expert Rev Clin Immunol; 2016 Jul; 12(7):787-96. PubMed ID: 26967382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adaptive immune response and associated trigger factors in atopic dermatitis].
    Heratizadeh A; Werfel T; Rösner LM
    Hautarzt; 2015 Feb; 66(2):96-102. PubMed ID: 25532900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin Treatment with Detergent Promotes Protease Allergen-Dependent Epicutaneous Sensitization in a Manner Different from Tape Stripping in Mice.
    Ochi H; Takai T; Shimura S; Maruyama N; Nishioka I; Kamijo S; Iida H; Nakae S; Ogawa H; Okumura K; Ikeda S
    J Invest Dermatol; 2017 Jul; 137(7):1578-1582. PubMed ID: 28259686
    [No Abstract]   [Full Text] [Related]  

  • 24. DC-SIGN promotes allergen uptake and activation of dendritic cells in patients with atopic dermatitis.
    Zhang Y; Luo Y; Li W; Liu J; Chen M; Gu H; Wang B; Yao X
    J Dermatol Sci; 2016 Nov; 84(2):128-136. PubMed ID: 27554335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis.
    Newell L; Polak ME; Perera J; Owen C; Boyd P; Pickard C; Howarth PH; Healy E; Holloway JW; Friedmann PS; Ardern-Jones MR
    J Invest Dermatol; 2013 Oct; 133(10):2372-2380. PubMed ID: 23528819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous barrier dysfunction in allergic diseases.
    Leung DYM; Berdyshev E; Goleva E
    J Allergy Clin Immunol; 2020 Jun; 145(6):1485-1497. PubMed ID: 32507227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atopic dermatitis: new evidence on the role of allergic inflammation.
    Heratizadeh A
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):458-64. PubMed ID: 27490127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral tolerance inhibits atopic dermatitis-like type 2 inflammation in mice by modulating immune microenvironments.
    Baek JO; Roh JY; Jung Y
    Allergy; 2017 Mar; 72(3):397-406. PubMed ID: 27325577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of skin barrier impairment in atopic dermatitis with aeroallergen sensitization.
    De Marchi F; Piacentini GL; Piazza M; Sandri M; Boner AL; Peroni DG
    Allergy Asthma Proc; 2015; 36(6):e127-33. PubMed ID: 26534744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs.
    Olivry T; Wofford J; Paps JS; Dunston SM
    Vet Dermatol; 2011 Apr; 22(2):188-96. PubMed ID: 21143539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressive effects of primed eosinophils on single epicutaneous sensitization through regulation of dermal dendritic cells.
    Lin JY; Ta YC; Liu IL; Chen HW; Wang LF
    Exp Dermatol; 2016 Jul; 25(7):548-52. PubMed ID: 26990208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epicutaneous administration of papain induces IgE and IgG responses in a cysteine protease activity-dependent manner.
    Iida H; Takai T; Hirasawa Y; Kamijo S; Shimura S; Ochi H; Nishioka I; Maruyama N; Ogawa H; Okumura K; Ikeda S
    Allergol Int; 2014 Jun; 63(2):219-26. PubMed ID: 24662805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the skin in the development of chemical respiratory hypersensitivity.
    Kimber I
    Toxicol Lett; 1996 Aug; 86(2-3):89-92. PubMed ID: 8711782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin barrier disruption: a requirement for allergen sensitization?
    De Benedetto A; Kubo A; Beck LA
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):949-63. PubMed ID: 22217737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial barrier repair and prevention of allergy.
    Goleva E; Berdyshev E; Leung DY
    J Clin Invest; 2019 Apr; 129(4):1463-1474. PubMed ID: 30776025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
    Kabashima K
    J Dermatol Sci; 2013 Apr; 70(1):3-11. PubMed ID: 23473856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dermatitis in early infancy as a risk factor for sensitization and allergic diseases during the first year of life].
    Shibuya N; Saito E; Karasawa C
    Arerugi; 2013 Dec; 62(12):1598-610. PubMed ID: 24608649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic analysis of experimental food allergen-induced cutaneous reactions.
    Prescott VE; Forbes E; Foster PS; Matthaei K; Hogan SP
    J Leukoc Biol; 2006 Aug; 80(2):258-66. PubMed ID: 16861616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.
    Han H; Roan F; Ziegler SF
    Immunol Rev; 2017 Jul; 278(1):116-130. PubMed ID: 28658558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march.
    Egawa G; Kabashima K
    J Allergy Clin Immunol; 2016 Aug; 138(2):350-358.e1. PubMed ID: 27497277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.